These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 31719292)
1. Anti-thymocyte globulin in haematology: Recent developments. Siddiqui S; Cox J; Herzig R; Palaniyandi S; Hildebrandt GC; Munker R Indian J Med Res; 2019 Sep; 150(3):221-227. PubMed ID: 31719292 [TBL] [Abstract][Full Text] [Related]
2. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
3. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Kim H; Lee JH; Joo YD; Bae SH; Hyun MS; Lee JH; Kim DY; Lee WS; Ryoo HM; Kim MK; Park JH; Lee KH; Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363 [TBL] [Abstract][Full Text] [Related]
4. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Doney KC; Weiden PL; Storb R; Thomas ED Am J Hematol; 1981; 11(1):1-8. PubMed ID: 7023233 [TBL] [Abstract][Full Text] [Related]
5. Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia. Chen X; Wei J; Huang Y; He Y; Yang D; Zhang R; Jiang E; Ma Q; Zhai W; Yao J; Zhang G; Feng S; Han M Biol Blood Marrow Transplant; 2018 Jan; 24(1):86-90. PubMed ID: 29032265 [TBL] [Abstract][Full Text] [Related]
6. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Scheinberg P; Nunez O; Wu C; Young NS Br J Haematol; 2006 Jun; 133(6):606-11. PubMed ID: 16704434 [TBL] [Abstract][Full Text] [Related]
7. Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse. Hoegh-Petersen M; Amin MA; Liu Y; Ugarte-Torres A; Williamson TS; Podgorny PJ; Russell JA; Grigg A; Ritchie D; Storek J Bone Marrow Transplant; 2013 Jan; 48(1):105-14. PubMed ID: 22659684 [TBL] [Abstract][Full Text] [Related]
8. [Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application]. Kulagin AD; Lisukov IA; Miloserdov IA; Afanas'ev BV Ter Arkh; 2010; 82(7):65-72. PubMed ID: 20853613 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980 [TBL] [Abstract][Full Text] [Related]
10. Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT. Giebel S; Labopin M; Czerw T; Socié G; Blaise D; Ghavamzadeh A; Passweg J; Ljungman P; Poiré X; Chevallier P; Reményi P; Rambaldi A; Anafasyev B; Fegueux N; Rovira M; Itälä-Remes M; Bornhäuser M; Mohty M; Nagler A Eur J Cancer; 2019 Jan; 106():212-219. PubMed ID: 30528805 [TBL] [Abstract][Full Text] [Related]
11. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R; Lancet Oncol; 2016 Feb; 17(2):164-173. PubMed ID: 26723083 [TBL] [Abstract][Full Text] [Related]
12. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Scheinberg P; Nunez O; Young NS Br J Haematol; 2006 Jun; 133(6):622-7. PubMed ID: 16704436 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation in pediatric patients with severe aplastic anemia: cyclophosphamide and anti-thymocyte globulin conditioning followed by recombinant human granulocyte-macrophage colony stimulating factor. Bunin N; Leahey A; Kamani N; August C J Pediatr Hematol Oncol; 1996 Feb; 18(1):68-71. PubMed ID: 8556374 [TBL] [Abstract][Full Text] [Related]
14. Antibodies in the treatment of aplastic anemia. Gómez-Almaguer D; Jaime-Pérez JC; Ruiz-Arguelles GJ Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):99-106. PubMed ID: 22307362 [TBL] [Abstract][Full Text] [Related]
15. Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Marsh J; Socie G; Tichelli A; Schrezenmeier H; Hochsmann B; Risitano AM; Fuehrer M; Bekassy AN; Korthof ET; Locasciulli A; Ljungman P; Bacigalupo A; Camitta B; Young NS; Passweg J; Br J Haematol; 2010 Aug; 150(3):377-9. PubMed ID: 20528874 [No Abstract] [Full Text] [Related]
16. How I manage aplastic anaemia in children. Samarasinghe S; Webb DK Br J Haematol; 2012 Apr; 157(1):26-40. PubMed ID: 22348483 [TBL] [Abstract][Full Text] [Related]
17. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183 [TBL] [Abstract][Full Text] [Related]
18. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis. Admiraal R; Nierkens S; de Witte MA; Petersen EJ; Fleurke GJ; Verrest L; Belitser SV; Bredius RGM; Raymakers RAP; Knibbe CAJ; Minnema MC; van Kesteren C; Kuball J; Boelens JJ Lancet Haematol; 2017 Apr; 4(4):e183-e191. PubMed ID: 28330607 [TBL] [Abstract][Full Text] [Related]
19. Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy. Duléry R; Mohty M; Duhamel A; Robin M; Beguin Y; Michallet M; Vigouroux S; Lioure B; Garnier A; El Cheikh J; Bulabois CE; Huynh A; Bay JO; Daguindau E; Ceballos P; Clément L; Dauriac C; Maillard N; Legrand F; Cornillon J; Guillerm G; François S; Lapusan S; Chevallier P; Damaj G; Yakoub-Agha I Biol Blood Marrow Transplant; 2014 May; 20(5):646-54. PubMed ID: 24462982 [TBL] [Abstract][Full Text] [Related]
20. Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology. Gaber AO; Monaco AP; Russell JA; Lebranchu Y; Mohty M Drugs; 2010 Apr; 70(6):691-732. PubMed ID: 20394456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]